Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.355 USD | +0.64% | +11.61% | +0.21% |
Jul. 08 | Xeris Biopharma Appoints John Shannon as CEO | MT |
Jul. 08 | Xeris Biopharma Holdings, Inc. Announces CEO Changes | CI |
Chart calendar Xeris Biopharma Holdings, Inc.
Upcoming events on Xeris Biopharma Holdings, Inc.
Past events on Xeris Biopharma Holdings, Inc.
2024-06-06 02:00 pm | Jefferies Global Healthcare Conference |
2024-06-05 09:00 am | Annual General Meeting |
2024-05-09 08:30 am | Q1 2024 Earnings Call |
2024-05-09 07:00 am | Q1 2024 Earnings Release |
2024-04-09 11:00 am | Needham Healthcare Conference |
2024-03-11 11:20 am | Leerink Partners Global Biopharma Conference |
2024-03-06 08:30 am | Q4 2023 Earnings Call |
2024-03-06 07:02 am | Q4 2023 Earnings Release |
2024-02-13 10:00 am | Oppenheimer Healthcare Life Sciences Conference |
2024-01-11 03:00 pm | JPMorgan Healthcare Conference |
2023-11-09 08:30 am | Q3 2023 Earnings Call |
2023-11-09 07:00 am | Q3 2023 Earnings Release |
2023-09-28 12:40 pm | Cantor Global Healthcare Conference |
2023-09-11 09:30 am | H.C. Wainwright Global Investment Conference |
2023-08-08 08:30 am | Q2 2023 Earnings Call |
2023-08-08 07:00 am | Q2 2023 Earnings Release |
2023-06-08 10:30 am | Jefferies Healthcare Conference - Fireside Chat |
2023-06-07 09:00 am | Annual General Meeting |
2023-05-09 08:30 am | Q1 2023 Earnings Call |
2023-05-09 07:00 am | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2,72 1,49 82.42% | 20,4 22,2 -8.04% | 49,6 47,5 4.47% | 110 108 2.04% | 164 163 0.79% | 187 |
EBITDA Million USD | Released Forecast Spread | -121 -112 -8.79% | -82,1 -76,3 -7.57% | 0,00 0,00 - | -69,7 -61,6 -13.22% | -30,9 -19,5 -58.21% | -9,08 |
EBIT Million USD | Released Forecast Spread | -122 -119 -2.75% | -83,5 -80,5 -3.74% | -115 -91,8 -25.47% | -81,9 -81,6 -0.44% | -44,0 -41,3 -6.69% | -33,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -126 -124 -1.69% | -91,3 -88,4 -3.17% | -123 -99,6 -23.21% | -96,1 -99,8 3.7% | -63,5 -61,2 -3.78% | -56,4 |
Net income Million USD | Released Forecast Spread | -126 -124 -1.33% | -91,1 -88,4 -3.09% | -123 -98,2 -25.03% | -94,7 -102 7.07% | -62,3 -60,1 -3.57% | -58,0 |
EPS USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -1,55 -1,32 -17.2% | -0,70 -0,75 7.08% | -0,45 -0,43 -3.69% | -0,40 |
Announcement Date | 11/03/20 | 09/03/21 | 10/03/22 | 08/03/23 | 06/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 22,1 23,4 -5.64% | 25,3 25,5 -0.88% | 29,7 29,1 2.07% | 33,1 31,0 6.79% | 33,2 30,8 7.9% | 38,0 34,8 9.1% | 48,3 41,1 17.61% | 44,4 43,6 1.93% | 40,6 41,8 -2.81% | 45,8 | 49,2 | 51,7 | 52,2 | 54,5 |
EBITDA Million USD | Released Forecast Spread | -12,1 -13,6 10.88% | -11,2 -6,44 -73.98% | -3,15 | 0,19 | 2,37 | |||||||||
EBIT Million USD | Released Forecast Spread | -29,1 -28,9 -0.7% | -18,9 -27,9 32.32% | -18,8 -17,3 -8.26% | -15,2 -17,5 13.39% | -13,3 -19,1 30.53% | -16,0 -14,2 -12.88% | -4,91 -10,4 52.54% | -9,84 -9,51 -3.49% | -14,2 -10,7 -32.72% | -9,34 | -6,04 | -4,18 | -4,55 | -2,70 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -34,1 -31,2 -9.24% | -26,5 -30,2 12.16% | -22,2 -21,9 -1.02% | -13,3 -21,0 36.91% | -16,8 -25,0 32.68% | -20,5 -20,5 -0.28% | -12,5 -14,9 16.02% | -13,6 -14,6 6.95% | -18,7 -16,6 -12.37% | -15,5 | -12,3 | -10,5 | -9,50 | -7,65 |
Net income Million USD | Released Forecast Spread | -33,7 -32,7 -3.02% | -26,2 -30,4 14% | -21,8 -23,8 8.36% | -12,9 -22,4 42.15% | -16,8 -23,6 28.53% | -19,8 -17,5 -13.26% | -12,2 -15,5 21.55% | -13,4 -13,7 2.32% | -19,0 -16,6 -14.12% | -15,6 | -13,1 | -10,7 | -9,50 | -7,65 |
EPS USD | Released Forecast Spread | -0,25 -0,25 0% | -0,19 -0,23 15.56% | -0,16 -0,17 4% | -0,10 -0,16 37.5% | -0,12 -0,17 29.41% | -0,14 -0,13 -9.8% | -0,09 -0,12 22.41% | -0,10 -0,10 -2.04% | -0,14 -0,12 -20% | -0,11 | -0,09 | -0,07 | -0,07 | -0,06 |
Announcement Date | 11/05/22 | 10/08/22 | 09/11/22 | 08/03/23 | 09/05/23 | 08/08/23 | 09/11/23 | 06/03/24 | 09/05/24 | - | - | - | - | - |
2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | INNOVIVA, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Xeris Biopharma Holdings, Inc.
2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2024-07-09 | LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release |
2024-07-09 07:35 am | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
2024-07-02 05:05 am | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- XERS Stock
- Calendar Xeris Biopharma Holdings, Inc.